Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland

Medical Journal of Australia

Volumn 191, Issue 3, 2009, Pages 157-160

  Lambert, Stephen B ^a   Faux, Cassandra E ^a   Hall, Lisa ^b   Birrell, Frances A ^b   Peterson V, Karen ^b   Selvey, Christine E ^b   Sloots, Theo P ^a,b,c   Nissen, Michael D ^a   Grimwood, Keith ^a,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b QUEENSLAND HEALTH   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; AUSTRALIA; FUNDING; GROUPS BY AGE; HEALTH PROGRAM; HUMAN; INFANT; LABORATORY TEST; PROPHYLAXIS; VIRUS INFECTION; FEMALE; GASTROENTERITIS; MALE; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; VIROLOGY;

CHILD, PRESCHOOL; FEMALE; GASTROENTERITIS; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE; QUEENSLAND; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 70349573757     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2009.tb02727.x     Document Type: Article

References (15)

1. Grimwood K, Lambert SB. Rotavirus vaccines: opportunities and challenges. Hum Vaccin 2009; 5: 4-16.
2. Galati JC, Harsley S, Richmond P, Carlin JB. The burden of rotavirus-related illness among young children on the Australian health care system. Aust N Z J Public Health 2006; 30: 416-421. (Pubitemid 44614445)
3. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354: 23-33. (Pubitemid 43048948)
4. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354: 11-22. (Pubitemid 43048947)
5. Australian Government Department of Health and Ageing. Fact sheet: Australian Government funding of rotavirus vaccine. http://www.health.gov.au/ internet/main/publishing.nsf /Content /rotavirus-vaccine.htm (accessed Apr 2009).
6. Gilbert GL, Gidding HF, Backhouse J, et al. Varicella seroprevalence and vaccine uptake in preschool children [letter]. Med J Aust 2005; 182: 42. (Pubitemid 40089877)
7. National Health and Medical Research Council, Australian Research Council and Australian Vice-Chancellors' Committee. National statement on ethical conduct in human research. Canberra: Australian Government, 2007. http://www.nhmrc.gov.au/PUBLICATIONS/synopses/-files/e72.pdf (accessed Apr 2009).
8. Centers for Disease Control and Prevention. Delayed onset and diminished magnitude of rotavirus activity - United States, November 2007 - May 2008. MMWR Morb Mortal Wkly Rep 2008; 57: 697-700.
9. Graham J, Cook H, Roberts C, et al. An estimate of rotavirus vaccine efficacy following an outbreak of rotavirus gastroenteritis in Central Australia. Northern Territory Dis Control Bull 2008; 15: 8-13.
10. Lieberman JM, Huang X, Koski E, et al. Decline in rotavirus cases in the US after licensure of a live, oral rotavirus vaccine. 48th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy/46th Annual Meeting of the Infectious Diseases Society of America; 2008 Oct 25-28; Washington, DC, USA: G1-G437.
11. Lyon MJ, Wei G, Smith GA. Epidemic viral gastroenteritis in Queensland coincides with the emergence of a new norovirus variant. Commun Dis Intell 2005; 29: 370-373.
12. Kirk MD, Roberts L, Horvath J. Understanding gastroenteritis in elderly residents of aged-care facilities [editorial]. Med J Aust 2008; 189: 476-477.
13. Block SL, Vesikari T, Goveia MG, et al. Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life. Pediatrics 2007; 119: 11-18. (Pubitemid 46397837)
14. Torvaldsen S, McIntyre PB. Observational methods in epidemiologic assessment of vaccine effectiveness. Commun Dis Intell 2002; 26: 451-457.
15. Kirkwood CD, Cannan D, Bogdanovic-Sakran N, et al. Australian Rotavirus Surveillance Program: annual report, 2006-2007. Commun Dis Intell 2007; 31: 375-379.